Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata from 2 Randomized Clinical Trials Over a Median of 1.6 Years and Up to 3.6 Years of Exposure
Authors: Brett King, Justin Ko, Bianca Maria Piraccini, Yutaka Shimomura, Yves Dutronic
< PREVIOUS POSTER NEXT POSTER >
